Systemic sclerosis (scleroderma): open trials in China

8 open trials have a site in China. Registry data; only the trial team decides who can take part.

NCT07641634
A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.
Trial Treatment · Phase 1/2 · Prolium Bioscience, Inc
Peking University Third Hospital, Beijing · The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou · Guangdong Provincial People's Hospital, Guangzhou · The First Affiliated Hospital of Zhengzhou University, Henan · The First Affiliated Hospital of NanChang University, Nanchang · The Second Affiliated Hospital of Nanchang University, Nanchang · Nanjing Drum Tower hospital, Nanjing · Pingxiang People's Hospital, Pingxiang
Registry updated 2026-10-09
NCT06801119
Efficacy and Safety of HN2301 in Autoimmune Diseases（AIDs）
Trial Treatment · Phase 1 · Shenzhen MagicRNA Biotechnology Co., Ltd
The First Affiliated Hospital of University of Science and Technology of China, Hefei
Registry updated 2026-08-12
NCT06947460
CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH
Trial Treatment · Phase 1/2 · Beijing GoBroad Hospital
Beijing
Registry updated 2026-07-30
NCT07502105
Efficacy and Safety of Firsekibart in the Treatment of Systemic Sclerosis
Trial Treatment · Tongji Hospital
Tongji Hospital, Tong ji Medical Colledge, Wuhan
Registry updated 2026-04-20
NCT07470151
Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases
Trial Treatment · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Registry updated 2026-03-13
NCT06947473
Umbilical Cord Blood CD19-BCMA CART Cell Therapy for SLE-LN, SSc, andpSS PAH.
Trial Treatment · Phase 1/2 · Beijing GoBroad Hospital
Beijing GoBroad Hospital, Beijing
Registry updated 2026-03-03
NCT07000682
The Clinical Study on the Treatment of SSc With UTAA91 Injection.
Trial Treatment · Early phase 1 · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Registry updated 2025-07-18
NCT06417502
Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry
Research · Peking Union Medical College Hospital
Third Hospital of Peking University, Beijing · Peking Union Medical College Hospital, Beijing · Beijing Children's Hospital, Capital Medical University, Beijing · The Second Xiangya Hospital of Central South University, Changsha · Chidren's Hospital of Chongqing Medical University, Chongqing · Children's Hospital of Zhejiang University School of Medicine, Hangzhou · Children's Hospital of Nanjing Medical University, Nanjing · Shenzhen Children's Hospital, Shenzhen · The University of Hong Kong Shenzhen Institute of Research and Innovation (HKU-SIRI), Shenzhen
Registry updated 2024-05-16

All Systemic sclerosis (scleroderma) trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error